Edit ModuleEdit ModuleShow Tags
Edit ModuleShow Tags

Pittsburgh at the Forefront of The Brain Revolution

Alzheimer’s disease is the most expensive ailment to treat and the sixth-leading cause of death in the United States. Pittsburgh has become a battleground in the fight against the devastating illness, thanks to the decade-long quest of two Pittsburgh researchers whose work is on track to change the face of medicine and affect millions worldwide.



(page 1 of 3)


Editor’s note: Niki Kapsambelis is the author of “The Inheritance: A Family on the Front Lines of the Battle Against Alzheimer’s Disease,” which chronicles the story of Alzheimer’s research through the lens of the DeMoe family of North Dakota. Stricken with an extremely rare genetic mutation that guarantees early onset Alzheimer’s, the DeMoes have worked with the University of Pittsburgh since the early 2000s to significantly advance scientific understanding of the disease and most recently to pilot test experimental prevention drugs. Their bond with Pitt researchers — particularly Dr. William Klunk of the Alzheimer’s Disease Research Center — is detailed in “The Inheritance” and has helped the field move toward a cure.
 


 

In 1994, a soft-spoken young doctor with a keen interest in brain disorders approached a colleague at the University of Pittsburgh with an idea: He wanted to develop a way to view Alzheimer’s disease in a living patient.
 

What Bill Klunk had in mind was nothing short of revolutionary and maybe a tad bit quixotic. Alois Alzheimer had discovered the disease 88 years earlier, and for much of that time, very little was known about it — including how widespread and deadly it was.

Part of the reason for that fatal misunderstanding was that doctors couldn’t definitively diagnose Alzheimer’s until the patient died, when they were able to look at the brain under a microscope. Another part of the reason was that Alzheimer’s, like many seemingly intractable illnesses, is such a biologically complex disease.
When I was researching my book, “The Inheritance,” one doctor remarked to me that we know more about the outer reaches of the universe than the inner workings of the brain.

​Klunk wanted to change that, and with good reason: despite flying under the radar for a good chunk of the 20th century, Alzheimer’s now is the sixth-leading cause of death in the United States, affecting 5.4 million Americans. Developing effective treatment — not to mention a cure — has proven to be maddeningly elusive.
Researchers in the Alzheimer’s field knew they could better identify the disease’s biological underpinnings if they could see its progression in real time. In so doing, they’d be better able to develop more precise treatments to halt or even prevent it.

It was a task easier said than done, as Chester Mathis knew well. Mathis, a Pitt radiochemist, had been trying since the 1980s — first in California and later in Pittsburgh — to develop a compound that would highlight the abnormalities in an Alzheimer’s brain, without success. Despite his other accomplishments, that incomplete task stuck with him.

And so began a decade-long quest that propelled Bill Klunk and Chet Mathis into the company of other Pittsburgh doctors whose work would change the face of medicine and impact millions of people worldwide.

Maybe it’s a side effect of working in a city that forged steel to build the world’s infrastructure. Perhaps it’s a ripple effect from living among people who refuse to give up in the face of failure. Whatever the X-factor may be, Pittsburgh boasts an impressive history of medical breakthroughs, often against long odds — whether it’s the polio vaccine or a multi-organ transplant.

There are parallels between the quest for a polio vaccine and the search for an Alzheimer’s cure. During the post-World War II epidemic, polls showed that the only thing Americans feared more than polio was nuclear war. Today, polls indicate the only disease Americans fear more than Alzheimer’s is cancer — although Alzheimer’s kills more people than breast and prostate cancer combined.

For Klunk and Mathis, the formula for success was a combination of persistence, hard work and the quiet but unwavering support of a mentor. And through a touch of serendipity, that eventual breakthrough would find a portal to the public in the unlikely form of a quirky family from the oil fields of North Dakota who came to think of Pittsburgh as a second home.
 



Pitt’s Dr. Chester Mathis (left) and Dr. William Klunk (right) discovered Pittsburgh Compound B, which made it possible for researchers to view Alzheimer’s disease in a living brain. | Photo courtesy University of Pittsburgh
 

An unlikely pair

A Pennsylvania native, Bill Klunk was a geriatric psychiatrist who had been recruited to Pitt nine years earlier. He proposed a window into the progression of a disease that has baffled science since its discovery in 1906. Long assumed to be part of the natural aging process, Alzheimer’s symptoms — forgetfulness, loss of organizational skills, difficulty finding words and names, delusions, paranoia and mood swings, among others — mimic those of many other diseases. That was why a clinical diagnosis was so difficult; doctors had to confirm their hunches postmortem by slicing open the brain and using a microscope to view the rogue proteins that are the Alzheimer’s signature.

Chet Mathis came to Pitt in 1992, lured by the medical school’s reputation for excellence and the presence of a dedicated cyclotron, a 100-ton, $2 million particle accelerator used in radiochemistry.

When Klunk proposed developing a new compound, what he had in mind was a riff on what Mathis already had tried unsuccessfully earlier in his career: adding radioactive atoms (a process called “radiolabeling”) to a dye that would stick to amyloid, one of the two abnormal proteins that are found in an Alzheimer’s brain. When doctors scanned the patient’s brain, the amyloid — coated in radiolabeled dye — in theory would show up on a scan.

Basic biology was working against them, however, due to the blood-brain barrier — the body’s natural filtering system that bars most substances from crossing into the brain past a series of tightly joined cells. Doctors needed a recipe for a compound that would successfully breach that barrier and stick to amyloid, which forms cotton ball-like clumps between neurons and disrupts their ability to signal each other.

What followed in the next 10 years was nothing short of systematic failure for Klunk and Mathis. Compound after compound flopped — hundreds in all.

“There were a lot of lean years here,” Klunk says in his characteristically understated way.

Those years were potential career killers. When an academic scientist is a candidate for tenure or promotion, universities typically ask colleagues in related fields to offer feedback on that scientist’s publications and grants.

But Klunk wasn’t focused on establishing that kind of track record. He and Mathis were on a Holy Grail kind of quest, one critically important to the future of Alzheimer’s research — but not one many other scientists were willing to tackle. Fortunately for them, they had David Kupfer in their corner. Kupfer, chairman of Pitt’s Department of Psychiatry from 1983 through 2009, had recruited Klunk.

“The promissory note from me in recruiting young, bright people who are ambitious is to try to let them run with their passion and see if I can play the role of a facilitator and an older brother,” says Kupfer, now a distinguished professor emeritus.

Klunk and Mathis established a friendship outside the laboratory. The two took fly-fishing trips together, where their unspoken rule dictated that they could talk about anything except work.

“When times were tough, when we were trying to keep things going, the mantra to live by was: You can always talk about fishing at work, but you can’t talk about work while fishing,” Klunk jokes.

In fishing, life imitated their art. The men who worked weekends and evenings, long hours in the lab in search of the elusive compound, would be wading into icy water at dawn on days when 30 degrees seemed warm. When dusk fell and it was too dark to see, they turned on their headlights and kept casting, casting.

Outside of Pittsburgh, despite their lack of success, other researchers were beginning to take notice. Many quietly pleaded with Kupfer to allow the quest to continue because of its importance to the rest of the field.

Finally in 2000 — after failing for nearly a decade — a long-awaited breakthrough occurred. The duo swapped out their original base molecule, known as “Congo Red,” for a simpler one that carried only a single positive charge. Within months, Mathis and Klunk had created roughly 100 derivatives of their compound, the most successful of which would come to be known as “Pittsburgh Compound B,” or PiB. On Valentine’s Day 2002, they collaborated with the Uppsala University PET Center in Sweden to test their creation in a human being. They would never know her name; all they would learn was that she was young and that memory problems had forced her to give up her career in health care.

When they learned that the experiment was a success, they wrote her a letter of thanks and celebrated with lunch at Fuel and Fuddle.

The first patient dosed with PiB would die from Alzheimer’s disease, proving that PiB could trace the disease in a living brain — an important milestone. Now, if the field could come up with a drug that attacked amyloid protein, they could watch its progress in real time, and compare it to any changes in a patient’s symptoms.
 

Edit ModuleShow Tags
Edit Module

Edit Module Edit ModuleShow TagsEdit ModuleShow Tags
Edit Module Edit ModuleShow Tags

The Latest

Build or Remodel in 2018? Submit Your Home to Our Best of Design Contest

Categories include Best New and Best Renovated homes, Best Kitchens and Best Outdoor Space.

HGTV's Leanne Ford Partners With PPG on Perfect White Paints

Known for her signature "white on white" aesthetic, the star of "Restored by the Fords" shares her "fail proof" color choices.

Halloween in Pittsburgh: How to Embrace the Fright

From haunted houses and scary movies to pumpkin patches and zombie bars –– we are here to help you experience as much of the ghoulish holiday as you dare.

Perspectives: Mourning Without a Road Map

A 30-year-old woman “who had lost her father too soon” learns the importance of following a plan when saying goodbye.

On Fitness: Peace and Posture Instead of No Pain, No Gain

Client by client, personal trainer Ian Riggins is dismantling the aggressive side of the fitness industry.

Angling for Tranquility: The Lure of Kayak Fishing

Kayak fishing is growing in popularity as anglers discover the peaceful joys of casting a line from the water's surface.

MultiStories: Pittsburgh's Art Deco Obelisk – The Gulf Building

As the Gulf Building rose into Pittsburgh skyline in the early 1930s, the prospects of its owner were headed in the opposite direction.

“First Man” Author to Appear at Heinz History Center

James R. Hansen, author of the authorized Neil Armstrong biography, will speak about the astronaut’s life on Nov. 1.

Results Are In: Jobs are Plentiful in Pittsburgh

Glassdoor’s newly released city shortlist for hot jobs ranks Pittsburgh #1.

The 400-Word Review: The Old Man and the Gun

Robert Redford's alleged final performance is a quiet, fitting farewell.

Sandwich, Helmet, Teammates Await Bell’s Return to Steelers

Le’Veon Bell reportedly intends to return to the Steelers before the second Browns game on Oct. 28, but hasn’t yet. But that didn’t stop some of his teammates from trying to have some fun with Bell at the media’s expense.

A New Day for Craft Beer in Pittsburgh

Day Bracey, along with Ed Bailey and Mike Potter, forges a more inclusive approach to craft brewing.

Southern Cuisine Served with a Big Side of Hospitality

Sugar and Smoke owner Andrea Robinson not only wants to feed customers of her new eatery in Bloomfield –– she wants to know their names.

Meet Pittsburgh's 40 Under 40 Honorees for 2018

For two decades, Pittsburgh Magazine and PUMP have presented the annual 40 Under 40 list. And every year, 40 people who have been alive for less than four decades are chosen because of their career accomplishments, dogged volunteer work and commitment to the Pittsburgh region. This year is no different. Read on to learn more about some of our very best neighbors.

Restaurant Review: Pie for Breakfast

Pittsburgh gets an updated, all-day diner with a sense of place from the owners of Legume Bistro and Butterjoint.
Edit Module
Edit ModuleShow Tags


Halloween in Pittsburgh: How to Embrace the Fright

Halloween in Pittsburgh: How to Embrace the Fright

From haunted houses and scary movies to pumpkin patches and zombie bars –– we are here to help you experience as much of the ghoulish holiday as you dare.

Comments

“First Man” Author to Appear at Heinz History Center

“First Man” Author to Appear at Heinz History Center

James R. Hansen, author of the authorized Neil Armstrong biography, will speak about the astronaut’s life on Nov. 1.

Comments


All the foodie news that's fit to blog
Southern Cuisine Served with a Big Side of Hospitality

Southern Cuisine Served with a Big Side of Hospitality

Sugar and Smoke owner Andrea Robinson not only wants to feed customers of her new eatery in Bloomfield –– she wants to know their names.

Comments

Millie’s Is on the Move, and Kevin Sousa Will Make Ice Cream for Dinner

Millie’s Is on the Move, and Kevin Sousa Will Make Ice Cream for Dinner

Millie’s finds a new home in Homestead, and Kevin Sousa will host an ice cream dinner with OddFellows' Sam Mason at Superior Motors in Braddock.

Comments


Not just good stuff. Great stuff.
The 5 Best Places to Shop If You Have a Green Thumb

The 5 Best Places to Shop If You Have a Green Thumb

Hone your gardening skills at these top Pittsburgh-area nurseries, garden centers and shops.

Comments

The 5 Best Movie Theaters in Pittsburgh

The 5 Best Movie Theaters in Pittsburgh

A movie-going experience is about more than just the movie. PM Film Critic Sean Collier takes a break from movie reviews and shares the best spots for cocktails, classics and comfort.

Comments


House of 1000 Beers Is Not Exaggerating

House of 1000 Beers Is Not Exaggerating

There are actually more than 1,000 different varieties of beer available at the pleasant Warrendale bar and restaurant.

Comments

Phantom Fright Nights is Creepy, Essential Kennywood

Phantom Fright Nights is Creepy, Essential Kennywood

The Halloween attraction turns the playful park sinister in delightful ways.

Comments


Mike Prisuta's Sports Section

A weekly look at the games people are playing and the people who are playing them.
Sandwich, Helmet, Teammates Await Bell’s Return to Steelers

Sandwich, Helmet, Teammates Await Bell’s Return to Steelers

Le’Veon Bell reportedly intends to return to the Steelers before the second Browns game on Oct. 28, but hasn’t yet. But that didn’t stop some of his teammates from trying to have some fun with Bell at the media’s expense.

Comments

Shazier, Steelers Return to Cincinnati Still Seeking a Happy Ending

Shazier, Steelers Return to Cincinnati Still Seeking a Happy Ending

Sunday's return to Paul Brown Stadium will be the Steelers' first trip back since last December when linebacker Ryan Shazier went down and stayed down. But this time he’ll be back on the sideline with his team, and most significantly he’ll be back on his feet.

Comments


The movies that are playing in Pittsburgh –– and, more importantly, whether or not they're worth your time.
The 400-Word Review: The Old Man and the Gun

The 400-Word Review: The Old Man and the Gun

Robert Redford's alleged final performance is a quiet, fitting farewell.

Comments

The 400-Word Review: Halloween

The 400-Word Review: Halloween

Forty years later, a new "Halloween" resets most of the franchise and returns to form.

Comments


Everything you need to know about getting married in Pittsburgh today.
Pittsburgh Couples with Perfect New York City Proposals

Pittsburgh Couples with Perfect New York City Proposals

Another city of bridges provided the perfect backdrop for these romantic engagements.

Comments

Love and the Law: This Couple's Professor Nailed It

Love and the Law: This Couple's Professor Nailed It

When Julia Conley and Scott Scheinberg's law school professor predicted two people in the class would end up married to one another, they never imagined it would be them.

Comments


Weekly inspiration for your home from the editors of Pittsburgh Magazine
Build or Remodel in 2018? Submit Your Home to Our Best of Design Contest

Build or Remodel in 2018? Submit Your Home to Our Best of Design Contest

Categories include Best New and Best Renovated homes, Best Kitchens and Best Outdoor Space.

Comments

HGTV's Leanne Ford Partners With PPG on Perfect White Paints

HGTV's Leanne Ford Partners With PPG on Perfect White Paints

Known for her signature "white on white" aesthetic, the star of "Restored by the Fords" shares her "fail proof" color choices.

Comments